A controlled study of efficacy and safety in CT colonography preparation with Mosapride Citrate Hydrate
Not Applicable
Recruiting
- Conditions
- colorectal cancer, colorectal polyp
- Registration Number
- JPRN-UMIN000005094
- Lead Sponsor
- Kamigoto Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Serious medical conditions that may increase the risk of optical colonoscopy or are so severe that screening would have no benefit. 2) Gastric or intestinal stenosis, abdominal adhesions, bowel obstruction or perforation, toxic megacolon. 3) Evidence of an increased risk in carrying out bowel preparation or CTC exams. 4) Possibility of pregnancy. 5) Patients with psychological conditions that contraindicate colonoscopy or make them irrelevant to participate in the trial. 6) Iodine hypersensitivity. 7) Severe thyroid disease. 8) Claustrophobia. 9) Severe deafness. 10) Subjects whose eligibility for this clinical trial is not appropriate by other reasons.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PEG-C versus PEG-C + Mosapride Citrate Hydrate for bowel preparation before CT colonography to be asscessed by the amount of residual fluid.
- Secondary Outcome Measures
Name Time Method Comparative adherence of patients to PEG-C preparation and PEG-C + Mosapride Citrate Hydrate preparation. Frequency and nature of any adverse events.